BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6888248)

  • 1. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
    Wiechmann HW; Schuster P; Trieb G
    Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
    Wiechmann HW; Schuster P; Trieb G
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
    Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
    Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
    Jansen W; Meyer L; Tauchert M
    Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
    Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
    Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
    Isbary J; Doering W; Wauer B; Greding H; König E
    Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
    Poliner LR; Ritter W; Wohl AJ; Nixon JV; Willerson JT
    Tex Med; 1977 Feb; 73(2):53-8. PubMed ID: 841487
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
    Schuster P; Trieb G; Wiechmann HW
    Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
    Riva E; Kurosaki M; Latini R
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):490-5. PubMed ID: 1279297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery dilation and hemodynamic responses after isosorbide dinitrate therapy in patients with coronary artery disease.
    Badger RS; Brown BG; Gallery CA; Bolson EL; Dodge HT
    Am J Cardiol; 1985 Sep; 56(7):390-5. PubMed ID: 4036818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial pressure and working capacity as parameters for checking the development of tolerance under nitrate therapy.
    Tauchert M; Jansen W
    Z Kardiol; 1990; 79 Suppl 3():67-77. PubMed ID: 2099043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotherapy in coronary heart disease: comparison of two nitrate treatments.
    Wortmann A; Bachmann K
    Chronobiol Int; 1991; 8(5):399-408. PubMed ID: 1818788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
    Weidemann H; Schuon J; Schober B
    Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 18. Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
    Jansen W; Prenze R; Kümper H; Tauchert M
    Am J Cardiol; 1990 Jun; 65(21):16J-22J. PubMed ID: 2349913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
    Gloor HO; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
    Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
    Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.